UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 39, 2025

Elite Health Systems Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-26575	52-1842411
(State of other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)
(State of other jurisdiction of	(Commission	(I.R.S. Employer
incorporation or organization)	File Number)	Identification No.)
1131 W 6th Street
Ontario, CA		91762
(Address of principal executive offices)		(Zip Code)

1131 W 6th Street
Ontario, CA	91762
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code:

(949) 249-1170

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry onto a Material Agreement.

On June 39, 2025, ~~Elite~~the ~~Health~~Financial ~~Plan,~~Industry ~~Inc.~~Regulatory Authority (“~~Elite Health Plan~~FINRA”) anotified ~~wholly owned subsidiary of~~ Elite Health Systems Inc. (the “~~Registrant~~Company”) ~~was~~(i) ~~notified~~that byFINRA ~~the~~had ~~Centers~~all ~~for~~necessary ~~Medicare~~information ~~and~~to ~~Medicaid~~process ~~Services~~the ~~(“CMS”)~~Company’s ~~that~~request itto ~~has~~change ~~conditionally~~the ~~approved Elite Health Plan~~Company’s ~~Contract~~ticker ~~Year~~symbol ~~(CY)~~from ~~2026~~USNU ~~Medicare~~to ~~Advantage/Medicare~~EHSI –and ~~Prescription Drug~~ (~~MA-Only/MA-PD~~ii) ~~application.~~that ToFINRA ~~enter~~announced ~~into~~ the ~~contract~~change ~~with~~in ~~CMS~~the asCompany’s ansymbol ~~MA/MA-PD~~to ~~organization~~EHSI, ~~CMS~~effective ~~must~~June ~~also~~10, ~~approve~~2025, ~~Elite~~in ~~Health Plan~~FINRA’s ~~bid,~~June ~~including formulary~~9, as2025 ~~required~~Daily byList 42that ~~CFR~~includes ~~422~~information ~~Subpart~~about ~~D and 42 CFR 423 Subpart F. Additionally~~new, ~~Elite~~symbol ~~Health~~changes ~~Plan~~and ~~must complete all~~ other ~~required~~corporate ~~pre-implementation~~actions. ~~activities~~Accordingly, ~~including~~the ~~system~~Company’s ~~and~~new ~~data~~ticker ~~testing.~~EHSI Onwill ~~June~~commence 2,trading ~~2025,~~on ~~Elite~~the ~~Health~~OTC ~~Plan~~market ~~filed~~at the CYmarket ~~2026~~open ~~PBP~~on ~~HMO~~June ~~bid submission in partnership with Wakely Consulting Group~~10, ~~an experienced actuarial and consultant in the healthcare industry~~2025.

The CMS related regulatory process is complex and there can be no assurance that CMS will ultimately approve Elite Health Plan’s bid, or that if approved, that Elite Health Plan will be able to maintain its license under the Act or its approval with CMS.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 5, 2025
Date: June 9, 2025
	Elite Health Systems Inc.
	By:	/s/ Prasad Jeereddi
	Name:	Prasad Jeereddi
	Title:	Chairman and CEO

Filing Compare · Elite Health Systems Inc.